Press Releases - Kerecis

Lamed to Sell Fish-Skin Wound-Treatment Product in Germany, Austria and Switzerland

Kerecis Communications January 30, 2015 No Comments

Meets significant need for treatment of non-healing wounds Reykjavik / Isafjordur, January 30, 2015 – The German healthcare company Lamed GmbH will market and distribute the Kerecis fish-skin wound-treatment product…

Kerecis Fish-Skin Treatment Receives Medicare “Q” Code

Kerecis Communications November 12, 2014 No Comments

Reykjavik / Isafjordur, November 12, 2014 – The Centers for Medicare and Medicaid Services (CMS) has awarded a “Q” code to the new tissue-regeneration material from Kerecis Limited. This means…

Kerecis Selected to Present at the Northern Prime Minister Meeting

Kerecis Communications November 6, 2014 No Comments

Reykjavik / Isafjordur, November 6, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, will present at the Northern Future Forum in Helsinki November 7. The forum is the…

Kerecis to Participate in the Military Health System Research Symposium, August 18 to 21

Kerecis Communications August 14, 2014 No Comments

Reykjavik / Isafjordur, August 14, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, will participate in the Military Health System Research Symposium (MHSRS) August 18 to 21. Kerecis…

Kerecis to Present at NASDAQ OMX

Kerecis Communications May 23, 2014 No Comments

Reykjavik / Isafjordur, May 23, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, will participate in the NASDAQ OMX Iceland Prospect Conference on Tuesday, May 27, at 2:15…

Kerecis to Participate in the Nordic Oncoplastic and Reconstructive Breast Surgeons’ Conference May 8-9

Kerecis Communications May 5, 2014 No Comments

Reykjavik / Isafjordur, May 5, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, will demonstrate its MariGen Omega3 fish-skin surgical material at the 3rd nORBS (Nordic oncoplastic and…

Fish-Skin Medical Company Completes Funding Round

Kerecis Communications February 21, 2014 No Comments

Kerecis to use US$2 million investment to further develop its tissue-regeneration technology Reykjavik / Isafjordur, Iceland, February 21, 2014 – Kerecis Limited, the emerging tissue-regeneration company, today announced that it…

Kerecis Receives U.S. Patent for Fish-Skin-Based Tissue Regeneration Technology

Kerecis Communications February 13, 2014 No Comments

Patent protects fish-skin invention across multiple medical areas Reykjavik / Isafjordur, February 13th, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, has been awarded a U.S. patent for…

Does Fish Skin Reduce Scarring from Plastic Surgery?

Kerecis Communications January 24, 2014 No Comments

University Hospital of Iceland and Kerecis to collaborate on medical research Reykjavik / Isafjordur, January 24, 2014 – Kerecis Limited, the emerging leader in tissue-regeneration materials, and the University Hospital…

FDA Clears Fish-Skin Technology to Heal Human Wounds

Kerecis Communications November 7, 2013 No Comments

New treatment option for the millions suffering from chronic wounds Reykjavik / Isafjordur, November 7, 2013 – Kerecis Limited announced today that a 510(k) clearance has been received from the…

Kerecis Establishes Scientific Advisory Board of Leading Experts in Wound Care and Surgical Implants

Kerecis Communications August 8, 2013 No Comments

Reykjavik / Isafjordur, Iceland, August 8, 2013 – Kerecis Limited, the emerging tissue-regeneration company, today announced the formation of a corporate scientific advisory board consisting of recognized experts in wound…

New Board Members Join Kerecis

Kerecis Communications June 17, 2013 No Comments

Reykjavik / Isafjordur, Iceland, June 17, 2013 – Kerecis Limited, the emerging tissue-regeneration company, today announced that Andri Sveinsson and Kristjan Johannesson have been appointed to the company’s board of…

Kerecis Completes Successful Immunology Study

Kerecis Communications May 3, 2013 No Comments

Symposium on Advanced Wound Care, Denver, Colorado, May 3, 2013— Kerecis today announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen Omega3 technology. In the trial,…

Kerecis Completes US$ 1 Million Series A2 Funding

Kerecis Communications April 26, 2013 No Comments

Reykjavik / Isafjordur, Iceland, April 26, 2013 – Kerecis Limited, the emerging tissue-regeneration company, today announced that it has secured US$ 1 million in series A2 funding. The financing, a…

Kerecis Announces a Distribution Agreement with Medline Industries for the MariGen Omega3 Tissue-regeneration Technology

Kerecis Communications January 31, 2013 No Comments

Dubai, United Arab Emirates, January 31, 2013 — At the Arab Health Conference today, Kerecis announced the signing of a distribution agreement with Medline Industries, Inc. based in Mundelein, Illinois.…

Category: Press Releases